Complementary pathway enrichment and GSEA analyses revealed that individuals with YDC show elevated activity in chemical carcinogenesis, ROS and lipid metabolism, TNF signalling, and ribosome biogenesis—pathways associated with metabolic abnormalities, oxidative stress, immune suppression, and tumour proliferation (52–57). This evidence concerns the gene TNF and neoplasm.